Steward Partners Investment Advisory’s Arcadia Biosciences RKDA Stock Holding History

Steward Partners Investment Advisory’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1	Closed	–	–	1934
2017 Q3	$0	Hold	1	–	–	﹤0.01%	1744
2017 Q2	$0	Buy	+1	New	+$558	﹤0.01%	1684

Other funds holding RKDA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Steward Partners Investment Advisory's RKDA Position: Q4 2017 in Review

Steward Partners Investment Advisory sold out of Arcadia Biosciences (RKDA) in Q4 2017, closing a stake of 1 share.

Steward Partners Investment Advisory first reported a position in RKDA in Q2 2017 and held it in 2 quarters. The position peaked at $0 in Q3 2017. 8 funds tracked by Wall St. Rank hold RKDA as of Q4 2017.

Steward Partners Investment Advisory reported no remaining Arcadia Biosciences position as of Q4 2017 after selling out during the quarter.
Steward Partners Investment Advisory sold 1 Arcadia Biosciences share in Q4 2017.
Steward Partners Investment Advisory first reported a position in Arcadia Biosciences in Q2 2017 and held it in 2 quarters.
Steward Partners Investment Advisory's Arcadia Biosciences position peaked at $0 in Q3 2017.
8 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2017.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2017, filed 19 Jan 2018.